CROI CROI 2016 - CROI 2016: Press Conference Sessions CROI 2016 - CROI 2016: Press Conference Sessions http://www.croiconference.org/ en-us Copyright 2016, CROI. All Rights Reserved. Podcasts support@capitalreach.com > CROI http://www.croiwebcasts.org/console/player/29410.mp3?mediaType=feedmp3 Julie M. Overbaugh of CROI Chair and Fred Hutchinson Cancer Research Center, Seattle, WA, United States Susan P. Buchbinder of CROI Vice Chair and University of California, San Francisco, CA, United States Judith Currier of CROI Vice Chair and University of California, Los Angeles, CA, United States http://www.croiwebcasts.org/console/player/29410.mp3 Monday Press Conference: Welcome and Overview of CROI 2016 Julie M. Overbaugh of CROI Chair and Fred Hutchinson Cancer Research Center, Seattle, WA, United States Susan P. Buchbinder of CROI Vice Chair and University of California, San Francisco, CA, United States Judith Currier of CROI Vice Chair and University of California, Los Angeles, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29411.mp3?mediaType=feedmp3 "Chair" by Kevin M. De Cock of CDC, Nairobi, Kenya "SS - EBOLA: Sequelae of Ebola Virus Disease in Surviving Patients in Guinea: Postebogui Cohort" by Eric Delaporte of UMI 233-IRD/U1175-INSERM/Montpellier University, Montpellier, France "SS - EBOLA: Dynamics of Ebola Virus Clearance in Semen in Guinea" by Daouda Sissoko of INSERM U897, Bordeaux, France http://www.croiwebcasts.org/console/player/29411.mp3 Monday Press Conference: Discussion of Special Session – Ebola: One Year Later "Chair" by Kevin M. De Cock of CDC, Nairobi, Kenya "SS - EBOLA: Sequelae of Ebola Virus Disease in Surviving Patients in Guinea: Postebogui Cohort" by Eric Delaporte of UMI 233-IRD/U1175-INSERM/Montpellier University, Montpellier, France "SS - EBOLA: Dynamics of Ebola Virus Clearance in Semen in Guinea" by Daouda Sissoko of INSERM U897, Bordeaux, France 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29412.mp3?mediaType=feedmp3 "Chair" by Wafaa El-Sadr of ICAP at Columbia University, New York, NY, United States "OA9: A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women" by Jared M. Baeten of University of Washington, Seattle, WA, United States "OA9: Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women" by Annalene Nel of International Partnership for Microbicides, Paarl, South Africa http://www.croiwebcasts.org/console/player/29412.mp3 Monday Press Conference: Discussion of Oral Abstract Session 9 – Expanding the Toolbox for Prevention "Chair" by Wafaa El-Sadr of ICAP at Columbia University, New York, NY, United States "OA9: A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women" by Jared M. Baeten of University of Washington, Seattle, WA, United States "OA9: Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women" by Annalene Nel of International Partnership for Microbicides, Paarl, South Africa 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29494.mp3?mediaType=feedmp3 "Chair" by John Coffin of Tufts University, Medford, MA, United States "Chair" by Susan P. Buchbinder of University of California, San Francisco, CA, United States "OA1: HIV-1 Laboratory Contagion During Recombination Procedures With Defective Constructs" by Claudia Alteri of University of Rome Tor Vergata, Rome, Italy "OA5: Estimating the Lifetime Risk of a Diagnosis of HIV Infection in the United States" by Kristen Hess of US Centers for Disease Control and Prevention, Atlanta, GA, United States "OA5: Increased HIV Viral Suppression Among US Adults Receiving Medical Care, 2009-2013" by Heather Bradley of US Centers for Disease Control and Prevention, Atlanta, GA, United States "OA5: Narrowing the Gap in Life Expectancy for HIV+ Compared With HIV- Individuals" by Julia L. Marcus of Kaiser Permanente Northern California, Oakland, CA, United States "OA5: Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257" by Raphael J. Landovitz of David Geffen School of Medicine, University of California, Los Angeles, CA, United States http://www.croiwebcasts.org/console/player/29494.mp3 Tuesday Press Conference: Discussion of Oral Abstract Session 1 – SIV and HIV Pathogenesis and Oral Abstract Session 5 – Strategies for Testing and Linkage to Care: Are We Closing the Gap? "Chair" by John Coffin of Tufts University, Medford, MA, United States "Chair" by Susan P. Buchbinder of University of California, San Francisco, CA, United States "OA1: HIV-1 Laboratory Contagion During Recombination Procedures With Defective Constructs" by Claudia Alteri of University of Rome Tor Vergata, Rome, Italy "OA5: Estimating the Lifetime Risk of a Diagnosis of HIV Infection in the United States" by Kristen Hess of US Centers for Disease Control and Prevention, Atlanta, GA, United States "OA5: Increased HIV Viral Suppression Among US Adults Receiving Medical Care, 2009-2013" by Heather Bradley of US Centers for Disease Control and Prevention, Atlanta, GA, United States "OA5: Narrowing the Gap in Life Expectancy for HIV+ Compared With HIV- Individuals" by Julia L. Marcus of Kaiser Permanente Northern California, Oakland, CA, United States "OA5: Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257" by Raphael J. Landovitz of David Geffen School of Medicine, University of California, Los Angeles, CA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29495.mp3?mediaType=feedmp3 "Chair" by Elaine J. Abrams of Columbia University, New York, NY, United States "OA3: Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial" by Harriet Nuwagaba-Biribonwoha of ICAP, Columbia University Mailman School of Public Health, New York, NY, United States "OA3: National HIV Transmission in 4-12 Week Olds in Malawi’s PMTCT Option B+ Program" by Sundeep Gupta of CDC, Harare, Zimbabwe "OA3: Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Mineral" by George K. Siberry of Eunice Kennedy Shriver NICHD, Bethesda, MD, United States "OA3: Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children" by Roger L. Shapiro of Harvard School of Public Health, Boston, MA, United States http://www.croiwebcasts.org/console/player/29495.mp3 Tuesday Press Conference: Discussion of Oral Abstract Session 3 – Prevention and Treatment of Pediatric HIV Infections "Chair" by Elaine J. Abrams of Columbia University, New York, NY, United States "OA3: Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial" by Harriet Nuwagaba-Biribonwoha of ICAP, Columbia University Mailman School of Public Health, New York, NY, United States "OA3: National HIV Transmission in 4-12 Week Olds in Malawi’s PMTCT Option B+ Program" by Sundeep Gupta of CDC, Harare, Zimbabwe "OA3: Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Mineral" by George K. Siberry of Eunice Kennedy Shriver NICHD, Bethesda, MD, United States "OA3: Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children" by Roger L. Shapiro of Harvard School of Public Health, Boston, MA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29630.mp3?mediaType=feedmp3 "Chair" by Diane Havlir of University of California, San Francisco, CA, United States "OA10: Botswana Is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage" by Tendani Gaolathe of Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana "OA10: Streamlining Antiretroviral Therapy Uptake: A Stepped-Wedge Cluster Randomized Trial" by Gideon Amanyire of Makerere University College of Health Sciences, Kampala, Uganda "OA10: HIV Mortality by Care Cascade Stage and Implications for Universal ART Eligibility" by Jeffrey Eaton of Imperial College London, London, United Kingdom "SS5: Missing But in Action: Where Are the Men?" by Helen Ayles of London School of Hygiene & Tropical Medicine, London, United Kingdom "SS5: Innovations in Antiretroviral Therapy Delivery" by Anna Grimsrud of International AIDS Society, Cape Town, South Africa http://www.croiwebcasts.org/console/player/29630.mp3 Wednesday Press Conference: Discussion of Oral Abstract Session 10 – Getting to 90-90-90 and Symposium Session 5 – Reaching 90-90-90 and Beyond: Challenges and Innovations "Chair" by Diane Havlir of University of California, San Francisco, CA, United States "OA10: Botswana Is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage" by Tendani Gaolathe of Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana "OA10: Streamlining Antiretroviral Therapy Uptake: A Stepped-Wedge Cluster Randomized Trial" by Gideon Amanyire of Makerere University College of Health Sciences, Kampala, Uganda "OA10: HIV Mortality by Care Cascade Stage and Implications for Universal ART Eligibility" by Jeffrey Eaton of Imperial College London, London, United Kingdom "SS5: Missing But in Action: Where Are the Men?" by Helen Ayles of London School of Hygiene & Tropical Medicine, London, United Kingdom "SS5: Innovations in Antiretroviral Therapy Delivery" by Anna Grimsrud of International AIDS Society, Cape Town, South Africa 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29631.mp3?mediaType=feedmp3 "Chair" by Sharon L. Hillier of University of Pittsburgh School of Medicine, Magee-Womens Hospital, PA, United States "OA9: ÉCLAIR: Phase 2A Safety and PK Study of Cabotegravir LA in HIV Uninfected Men" by Martin Markowitz of Aaron Diamond AIDS Research Center, New York, NY, United States "TD12: Higher Cumulative TFV/FTC Levels in PrEP Associated With Decline in Renal Function" by Monica Gandhi of University of California San Francisco, San Francisco, CA, United States "TD12: Changes in Renal Function Associated With TDF/FTC PrEP Use in the US Demo Project" by Albert Y. Liu of San Francisco Dept of Public Health, San Francisco, CA, United States "TD12: STI Data From Community-Based PrEP Implementation Suggest Changes to CDC Guidelines" by Sarit A. Golub of Hunter College, City University of New York, NY, United States "PAS3: HPTN 073: PrEP Uptake and Use by Black Men Who Have Sex With Men in 3 US Cities" by Darrell P. Wheeler of State University of New York at Albany, Albany, NY, United States http://www.croiwebcasts.org/console/player/29631.mp3 Wednesday Press Conference: Discussion of Oral Abstract Session 9 – Expanding the Toolbox for Prevention and Themed Discussion Session 12 – It's Complicated: Renal Function and STIs in PrEP Users and Poster Abstract Session 3 – Predictors of PrEP Coverage and Uptake "Chair" by Sharon L. Hillier of University of Pittsburgh School of Medicine, Magee-Womens Hospital, PA, United States "OA9: ÉCLAIR: Phase 2A Safety and PK Study of Cabotegravir LA in HIV Uninfected Men" by Martin Markowitz of Aaron Diamond AIDS Research Center, New York, NY, United States "TD12: Higher Cumulative TFV/FTC Levels in PrEP Associated With Decline in Renal Function" by Monica Gandhi of University of California San Francisco, San Francisco, CA, United States "TD12: Changes in Renal Function Associated With TDF/FTC PrEP Use in the US Demo Project" by Albert Y. Liu of San Francisco Dept of Public Health, San Francisco, CA, United States "TD12: STI Data From Community-Based PrEP Implementation Suggest Changes to CDC Guidelines" by Sarit A. Golub of Hunter College, City University of New York, NY, United States "PAS3: HPTN 073: PrEP Uptake and Use by Black Men Who Have Sex With Men in 3 US Cities" by Darrell P. Wheeler of State University of New York at Albany, Albany, NY, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29749.mp3?mediaType=feedmp3 "Chair" by Harold W. Jaffe of US Centers for Disease Control and Prevention, Atlanta, GA, United States "PL6: The Evolving Epidemiology of HIV Infection in Persons Who Inject Drugs: Indiana 2015" by John Brooks of US Centers for Disease Control and Prevention, Atlanta, GA, United States "OA13: Networks of HCV Transmissions Among Persons Who Inject Drugs: Indiana, 2015" by Sumathi Ramachandran of US Centers for Disease Control and Prevention, Atlanta, GA, United States http://www.croiwebcasts.org/console/player/29749.mp3 Thursday Press Conference: Discussion of Plenary Session 6 – The Evolving Epidemiology of HIV Infection in Persons Who Inject Drugs: Indiana 2015 and Oral Abstract Session 13 – HCV: Curing the Patient but Not the Population "Chair" by Harold W. Jaffe of US Centers for Disease Control and Prevention, Atlanta, GA, United States "PL6: The Evolving Epidemiology of HIV Infection in Persons Who Inject Drugs: Indiana 2015" by John Brooks of US Centers for Disease Control and Prevention, Atlanta, GA, United States "OA13: Networks of HCV Transmissions Among Persons Who Inject Drugs: Indiana, 2015" by Sumathi Ramachandran of US Centers for Disease Control and Prevention, Atlanta, GA, United States 00:00:00.0 Podcasts Podcasts > CROI http://www.croiwebcasts.org/console/player/29750.mp3?mediaType=feedmp3 "Chair" by Richard Chaisson of Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, United States "OA14: Empirical TB Treatment in Advanced HIV Disease: Results of the TB Fast Track Trial" by Alison Grant of London School of Hygiene & Tropical Medicine, London, United Kingdom "OA14: Acceptability of Large-Scale Household-Based TB Screening: HPTN 071 (PopART)" by Comfort R. Phiri of ZAMBART, Lusaka, Zambia "OA14: HIV-Associated XDR TB Is Transmitted in Households and Hospitals in South Africa" by Sara C. Auld of Emory University, Atlanta, GA, United States "OA14: Pre-ART Cryptococcal Antigen Titer Associated With Preemptive Fluconazole Failure" by Bozena M. Morawski of University of Minnesota, Minneapolis, MN, United States http://www.croiwebcasts.org/console/player/29750.mp3 Thursday Press Conference: Discussion of Oral Abstract Session 14 – Tuberculosis and Other Opportunistic Infections/Cancer Prevention: Hits and Misses "Chair" by Richard Chaisson of Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, United States "OA14: Empirical TB Treatment in Advanced HIV Disease: Results of the TB Fast Track Trial" by Alison Grant of London School of Hygiene & Tropical Medicine, London, United Kingdom "OA14: Acceptability of Large-Scale Household-Based TB Screening: HPTN 071 (PopART)" by Comfort R. Phiri of ZAMBART, Lusaka, Zambia "OA14: HIV-Associated XDR TB Is Transmitted in Households and Hospitals in South Africa" by Sara C. Auld of Emory University, Atlanta, GA, United States "OA14: Pre-ART Cryptococcal Antigen Titer Associated With Preemptive Fluconazole Failure" by Bozena M. Morawski of University of Minnesota, Minneapolis, MN, United States 00:00:00.0 Podcasts Podcasts